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INTRODUCTION
The recent inauguration of the new European Association for
Cardio-Thoracic Surgery (EACTS) House in Windsor, UK by
the EACTS has provided an opportunity to set the stage for
a discussion about the future of the profession. As most of
the leaders of this organization had trained, worked,
researched, lived and/or taught on several continents
throughout their career, it was clear from the very beginning,
that a global view should be taken, bringing in the expertise
and views from other continents. The goal of this contribu-
tion is to outline some of the challenges and opportunities
in Asia.
ASIA AS A CONTINENT
Asia is the largest continent surface-wise and population-wise.
Geographically, Asia spreads from the Ural eastwards to Siberia
and includes in the south some heavyweights like India, China
and Japan. However, there are in total 48 nations with un-
countable regional differences (e.g. Singapore vs Mongolia)
and there is unmatched diversity in populations, languages,
traditions, religions, etc. Indonesia alone has >17 500 islands.
This to state that there cannot only be enormous distances in-
between Asian regions, but communication can be compli-
cated and even more so transportation for the healthy, not to
think about the sick. Although ﬁrst-class health service includ-
ing cardio-thoracic and vascular surgery at the highest level is
available in the leading Asian cities, this is certainly less the
case in remote areas. Considering the communication and
transportation challenges outlined above, there is in fact today
marked diversity in Asia not only with regard to culture, but
even more so with regard to medical culture, i.e. service level,
service availability, access to service and, of course, cost of
service.
CARDIO-THORACIC AND CARDIO-VASCULAR
SURGERY IN ASIA
More speciﬁcally, the regional differences in thoracic and cardio-
vascular surgery in Asia may be even more pronounced than on
other continents. Not only are there areas in Asia with expertise
and facilities equal to anywhere in the world, but many centres
perform 6000–10 000 cardiac surgeries in a year. Furthermore,
rapid growth of cardiac surgery has been witnessed over the
past 10 years in countries such as Vietnam and Bangladesh. On
the other hand, some countries have no cardiac surgery or are
just building facilities and training personnel. In many places, al-
location of resources is focussed on major cities. Less is spent on
second and third tier cities, although typically these cities still
have millions of population deserving cardio-thoracic care.
An additional concern is the limitations in training for some
places. Problems exist in supervision, small volumes in smaller
hospitals, lack of certiﬁcation, inadequate basic science founda-
tion, poor medical school standard, poor command of English,
inability to publish signiﬁcant work, lack of system of supervision
and review of trainees, no outcome assessment and insufﬁcient
platform for continued professional development. Other issues
are professionalism and ethics. As a matter of fact, commercial-
ization of the practice of cardiac surgery is associated with
reduced patient’s trust. Sometimes patient’s interest is not para-
mount. Movement of surgeons into private practice reduces the
mentors and teachers in training institutions.
A different issue in Asia is the not uncommon focus on ‘high-
tech’ surgery with unproven longer-term outcomes. In most
parts of Asia, it would be conventional surgery that can deliver
the results patients expects. Excessive interest in early-stage high-
tech surgery may not be beneﬁcial to most patients, be it only
cost wise, limiting its potential beneﬁts to very few patients.
Thorough analysis of this and other issues is further complicated
by the absence of adequate databases that allow for the assess-
ment of early and longer-term outcomes with the required read-
justments for optimized patient care.
The extreme discrepancies from one Asian region to another are
also reﬂected in long periods of training under less than ideal
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circumstances, and inadequate pay for many surgeons and trainees.
As a result, training in cardiac surgery has become an unpopular
choice in several parts of Asia. However, in other regions of Asia,
cardiac surgeons are well remunerated and have satisfying careers.
ASIA’S OPPORTUNITIES FOR THORACIC AND
CARDIO-VASCULAR SURGERY
Most parts of Asia have a growing ageing population with in-
creasing resources and growing awareness of health issues.
Hence, there is an increasing demand for cardiac and other sur-
geries in many parts of Asia. One key issue is, however, how can
the specialty of thoracic and cardio-vascular surgery provide
top-quality surgery to care for the large numbers of patients.
Considering the enormous potential, the 21st century may well
be an Asian century. But ‘Asia’ is not a single entity. It is a vast con-
tinent of diversity, of widely contrasting countries and regions in
varying stages of development. Although economic and social
progress in Asia is well documented, its distribution is extremely
scattered. The percentage share of world gross domestic product
of developing countries has already equalled that of the devel-
oped nations. Asia accounts for the majority of the overall growth.
Asian countries have by now 60% of the world’s population, and
an ever increasing cardio-vascular disease ‘burden’. It has been
estimated that India has currently 60% of world’s heart disease
burden [1]. Many Asian countries have rapidly ageing populations
(China, Japan and Singapore) and will likely have increasing inci-
dence and prevalence of complex cardiac diseases. China already
has >200 million people above age of 65 years [2] and 60–70% of
males are smokers [3]. Coronary heart disease is rapidly increasing
in China. An ageing population by itself will increase cardio-
vascular events in China by 50% from 2010 to 2030 [4]. Increasing
wealth implies increased affordability and accessibility to cardiac
surgery. How much the actual increase in thoracic and cardio-
vascular surgery will be is uncertain. Projections are often inaccur-
ate and even more so in Asia.
As indicated above, a major issue is how to cope with the
expected increasing need for cardiac surgery. In India, the esti-
mated number of patients requiring cardiac surgery is at least 8
million. Coronary artery disease in India was estimated to affect
30 million patients [5, 6], whereas the current volume of cardiac
surgery is about 120 000 a year. If we assume 10% of potential
coronary surgery patients can actually afford surgery (800 000
patients), there is already a mismatch between demand and
current facilities and manpower.
A similar situation exists in China. Assuming there is a sufﬁcient
economic development to provide for the healthcare needs of
the population, do we have the mechanism to provide high-
quality cardiac surgery over the next two decades in Asia? Taking
into context, the long lag time needed to train independent
cardiac surgeons and teams, training certainly is a major issue.
There is also a bright side. The continent of Asia is full of
capable, smart, hungry and hard-working people, increasingly
better trained, resourced and organized. The support structures
are improving. We are witnessing the phenomenon of excellent
surgeons and researchers moving to Asia from the west, in a
‘reverse brain drain’. This trend is welcomed in many Asian
countries. It certainly helps to speed up the development of the
specialty. As a matter of fact, there is already a substantial contri-
bution from Asia to the publications in the European Journal of
Cardio-Thoracic Surgery considering that for the ﬁrst issue
of 2012 immediately prior to our meeting at EACTS House, 15 of
the 59 (25%) contributions originate from Asia (Table 1).
THE ACADEMY OF THE ASIAN SOCIETY FOR
CARDIO-VASCULAR AND THORACIC SURGERY
As a fraternity of cardiac surgeons, we can be part of a move-
ment to produce the best possible surgeons and surgical teams,
all across Asia. We will beneﬁt millions of patients.
The Academy of the Asian Society for Cardio-Vascular and
Thoracic Surgery (ASCVTS) had recently been established. The
aim is to help educate and train cardio-thoracic surgeons, provide
avenues for professional development, develop cognitive capaci-
ties and enhance the specialty of cardio-thoracic surgery.
Seminars and workshops are to be conducted, using interactive
discussions, box trainers, 3D printing, training models, wet and
dry labs as adjuncts. Simulation will be a key modality. It is an ex-
cellent platform for training in cardiac procedures such as trans-
catheter aortic valve implantation, extracorporeal membrane
oxygenation, extracorporeal circulation, minimally invasive thora-
coscopic assisted mitral surgery and robotics. Efforts are under-
way to develop open surgery simulation trainer using a Robotic
Glove linked to gaming systems.
There already are such existing teaching facilities in Singapore
(Figure 1), Beijing, Hong Kong and Japan for the purposes of the
ASCVTS Academy, including simulation centres, animal labs,
modern training aids, wet and dry labs. More sites in other
countries will be recruited and developed. Teaching expeditions
to developing regions of Asia are planned.
Longer-term targets are the formulation of Asian risk scores, guide-
lines, multicentre trials, curriculum development and certiﬁcation.
Our motto is: ‘Think big, start small, and move fast’. The
academy is expected to be a major driver of education and train-
ing in Asia, supplementing the yearly congresses of the ASCVTS.
WHAT CAN EACTS DO?
The EACTS is a successful organization with a proven track
record that can rely on a vast pool of people of ﬁrst-class intel-
lect with unique experience of coordinating a diverse continent
of surgeons into working for common good. The experience
gained is invaluable. EACTS can be a major partner of ASCVTS in
developing excellence in Asia. In many situations, Asia does not
need to reinvent the wheel. We can learn from our friends in
Europe, if EACTS can extend ‘hands across mountains’.
Although the basic principles of training are universal, not
everything that worked in the west can be transposed in entirety
to all regions of Asia. Modiﬁcations and awareness of cultural
sensitivities would be necessary.
WHAT CAN ASIA CONTRIBUTE?
Ability to innovate is not conﬁned to developed countries. There
is abundance of talents within Asia’s thoracic and cardio-
vascular, scientiﬁc and engineering communities.
The quantum of funding for research and medical technology
development has signiﬁcantly increased. The infrastructure for
innovation is becoming well organized. There is abundance of
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energetic engineers and scientists in institutions keen to be our
collaborators. More and more Asian universities and medical
schools are ranked among the top in the world. Major medical in-
dustry companies are incentivized to set up research and develop-
ment centres in Asia. The regulatory environment for innovation
and clinical trials can be less stiﬂing than many places in the west.
There is large number of patients in many countries. In time
to come, Asia may lead in developing the cutting edge for thor-
acic and cardio-vascular surgery.
CONCLUSION
There is a great need for thoracic and cardio-vascular surgery in
Asia in the 21st century. Asian thoracic and cardio-vascular
surgery will grow, but may not be able to meet with the
demands on the volume requirement with the requisite
quality. We as a fraternity across the world should work together
to help provide the best possible care to billions of people in
Asia.
Two poems, one from the west, one from the east, express
Asia’s intention.
Come, my friends. Sail, beyond the sunset.
To Strive, to Seek, To Find and not to Yield
–Alfred Lord Tennyson, ‘Ulysses’
You are an eagle.
You have skies stretching out before you.
Do not let mere day and night ensnare you
–Muhammad Iqbal, ‘Tulips in the Desert’
Table 1: Publications originating from Asia in the first issue 2012 of the European Journal of Cardio-Thoracic Surgery (volume
41, issue 1, 2012): 15 of the 59 contributions or 25%
References First author Domain City Country
[7] Esme et al. Thoracic Konya Turkey
[8] Matsuguma et al. Thoracic Utsunomiya Japan
[9] Okamoto et al. Thoracic Chiba Japan
[10] Park et al. Thoracic Seoul Korea
[11] Li et al. Adult cardiac Shanghai China
[12] Marui et al. Adult cardiac Kyoto Japan
[13] Kinoshita et al. Adult cardiac Otsu Japan
[14] Wang et al. Adult cardiac Tianjin China
[15] Chen et al. Adult cardiac Fouzhou China
[16] Xiong et al. Basic Science Guanzhou China
[17] Kimura et al. Case report Tokyo Japan
[18] Yurekli et al. Letter to the editor Izmir Turkey
[19] Jiwnani et al. Letter to the editor Mumbai India
[20] Kestelli et al. Letter to the editor Izmir Turkey
[21] Kim et al. Letter to the editor Seoul South Korea
Figure 1: A view of the state of the art training facility in Singapore organized by the Academy of the ASCVTS.
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We in our limited lifetime, operating on 1 patient at a time,
can only beneﬁt a few thousand patients. If we do our part in
training, research, innovation and in developing the infrastruc-
ture of thoracic and cardio-vascular surgery, we will certainly
beneﬁt a larger number of patients, for many years to come. We
have a higher calling than merely performing surgery.
Conﬂict of interest: none declared.
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